The AIDS epidemic in Sub-Saharan Africa continues to affect all facets of life throughout the subcontinent. Deaths related to AIDS have driven down the life expectancy rate of residents in Zambia, Kenya, and Uganda with far-reaching implications. This book details the current state of the AIDS epidemic in Africa and what is known about the behaviors that contribute to the transmission of the HIV infection. It lays out what research is needed and what is necessary to design more effective prevention programs.

These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention, treatment and care. This edition updates the 2013 consolidated guidelines on the use of antiretroviral drugs following an extensive review of evidence and consultations in mid-2015, shared at the end of 2015, and now published in full in 2016. It is being published in a changing global context for HIV and for health more broadly.

This book provides a comprehensive overview of behavioral interventions to prevent HIV-AIDS risk-related behaviors. It synthesizes the empirical literature on individual, group, and community-level interventions and provides an objective and detailed assessment of intervention outcomes. Factors associated with behavioral risk for HIV transmission, theories of HIV risk behavior change, and the state of HIV prevention technology transfer are also reviewed. Additionally, behavioral interventions for adolescents and adults of diverse ethnic and sexual backgrounds are discussed with respect to each intervention type. Although the focus is on sexual risk reduction, interventions for sexual behavior of substance abusing populations are also covered.

This volume addresses the interface of two major national problems: the epidemic of HIV-AIDS and the widespread use of illegal injection drugs. Should communities have the option of giving drug users sterile needles or bleach for cleaning needs in order to reduce the spread of HIV? Does needle distribution worsen the drug problem, as opponents of such programs argue? Do they reduce the spread of other serious diseases, such as hepatitis? Do they result in more used needles being carelessly discarded in the community? The panel takes a critical look at the available data on needle exchange and bleach distribution programs, reaches conclusions about their efficacy, and offers concrete recommendations for public policy to reduce the spread of HIV/AIDS. The book includes current knowledge about the epidemiologies of HIV/AIDS and injection drug use; characteristics of needle exchange and bleach distribution programs and views on those programs from diverse community groups; and a discussion of laws designed to control possession of needles, their impact on needle sharing among injection drug users, and their implications for needle exchange programs.

Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.

-The latest "buzz word" in HIV prevention -Few resources available on "positive prevention" -Kalichman is a known and recognized name in the field of HIV prevention

Learn how to create professional collaboration between HIV/AIDS researchers and community organizations for the benefit of all! This book is designed to help frontline prevention organizations answer two questions that are of utmost importance. First, how effective are their services; and second, can their work be improved? The absence of rigorous evaluation is a barrier to stable funding for community organizations, and the strategies in Preventing AIDS: Community-Science Collaborations can help overcome that barrier. The book is a guide to successful cooperative efforts between researchers and community-based organizations. The information it presents will help community-based programs acquire detailed, timely information on program effectiveness and outcomes. It also provides researchers with methods for accessing hard-to-reach or hidden HIV high-risk groups. Handy tables and figures make important data easy to access and understand. In Preventing AIDS: Community-Science Collaborations, you’ll learn about the difficult but critically important collaboration between community organizations who do frontline prevention work and university scientists who evaluate the effectiveness of that work. The book describes the community-researcher equal partner collaboration (CREPC) model for community-based collaborative research. In addition, it examines six unique efforts to prevent the spread of AIDS among high-risk populations, such as prostitutes, injection drug users, impoverished pregnant women, migrant workers, transgendered persons, and prison inmates. The case studies in Preventing AIDS: Community-Science Collaborations describe the frustrations of outreach workers and counselors who suddenly must help design a survey they fear will be intrusive, and the parallel problems faced by scientists who are told that their traditional measures mean little to outreach workers. Preventing AIDS: Community-Science Collaborations presents funders’ perspectives on collaborative AIDS research and examines the collaborative and funding aspects of: the CAL-PEP prevention programs for drug injectors and sex workers efforts to promote HIV prevention for migrant farm workers and evaluate those efforts’ effectiveness the ongoing collaboration between The Center for AIDS Prevention Studies (University of California, San Francisco), Centerforce (a statewide nonprofit agency providing services and advocacy to prisoners and their families), and San Quentin State Prison the effort of the Los Angeles County HIV Epidemiology Program and three community-based organizations, which collaborate to provide culturally appropriate outreach and HIV education/prevention services to transgendered individuals of various ethnic origins San Francisco’s PHREDA project and the way its creators collaborated to better understand and serve high-risk women The U-Find-Out (UFO) Study, funded by the Universitywide AIDS Research Program of the State of California

Based on careful analysis of burden of disease and the costs ofinterventions, this second edition of 'Disease Control Priorities in Developing Countries, 2nd edition' highlights achievable priorities; measures progresstoward providing efficient, equitable care; promotes cost-effectiveinterventions to targeted populations; and encourages integrated effortsto optimize health. Nearly 500 experts - scientists, epidemiologists, health economists,academicians, and public health practitioners - from around the worldcontributed to the data sources and methodologies, and identifiedchallenges and priorities, resulting in this integrated, comprehensivereference volume on the state of health in developing countries.

Public health has a legacy of neglect regarding social and behavioral research. Too often, prompted by technical and scientific progress, we have ignored even marginalized-the vital "human element" in health thinking and prac tice. Thus, for example, while family planning programs focused on providing a choice among safe and effective contraceptive methods (a supremely worthy goal), the central issue of sexuality and sexual behavior was generally neglected. Similarly, the enormous and important efforts to develop rapid and reliable diagnostic and treatment methods for sexually transmitted diseases helped divert attention away from the crucial issues of sexual practice. In short, we seem to have difficulty addressing the fundamental behaviors-including sex, drug taking and other intoxications, and violence-that are central to the major causes of preventable morbidity, disability, and premature mortality in the world today. Our collective reluctance to examine and understand ourselves is also expressed in the oft-repeated pipedream that scientific progress will "take care of" the HIV / AIDS pandemic by delivering a preventive vaccine, an effective cure, or both. Yet even a cursory glance at the relationship between scientific/ technical progress and health shows that meeting the scientific challenges is only one step toward effective application of the vaccine or drug. It is typical, not atypical, that hepatitis B vaccine is only now becoming relatively freely available to large populations in the developing world, more than a decade after the vaccine's licensure.